VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study. Read more.

Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

NOVEL molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at ...

PATIENTS with traumatic brain injury (TBI) and hypotension have a significantly increased risk of mortality, underscoring the importance of precise blood pressure management in clinical settings.

CAR T-cell therapy shows promise for solid tumors like glioblastoma. New engineering strategies and clinical trial results ...

No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation ...

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry's marketing compliance processes using AI.

A new report reveals high rates of preventable pregnancy-related cardiovascular deaths, underscoring racial disparities and ...